Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 366, Issue 6, 2002, Pages 587-595

  Rogines Velo, María Pía ^a   Pelorosso, Facundo Germán ^a   Zold, Camila Lidia ^a   Nowak, Wanda ^a   Pesce, Guido Oscar ^a   Sardi, Sergio Pablo ^a   Brodsky, Paula Tamara ^a   Rothlin, Rodolfo Pedro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

methyl 5 hydroxytryptamine; 5 HT; 5 HT2A receptors; Functional studies; Human umbilical vein; Ketanserin; Mesulergine; Prazosin; Radioligand binding assays; Spiperone

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA METHYLSEROTONIN; KETANSERIN TARTRATE; LIGAND; MESULERGINE; PRAZOSIN; RECEPTOR SUBTYPE; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN RECEPTOR; SPIPERONE; SEROTONIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CALCULATION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; DRUG SELECTIVITY; HUMAN; HUMAN TISSUE; MEMBRANE BINDING; NEWBORN; NONLINEAR SYSTEM; RADIOASSAY; RECEPTOR DENSITY; UMBILICAL VEIN; VENOCONSTRICTION; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; METABOLISM; METHODOLOGY; PHYSIOLOGY; VASOCONSTRICTION;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; UMBILICAL VEINS; VASOCONSTRICTION;

EID: 0036446854     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0636-9     Document Type: Article

References (49)

1. (2C) receptors in the rabbit: High correlation with the profile for the human receptors. Eur J Pharmacol 406:163-169
2. Altura BM, Malaviya D, Reich CF, Orkin LR (1972) Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 222:345-355
3. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
4. 2 receptor subtypes: A family re-united? Trends Pharmacol Sci 16:105-110
5. Boura AL, Walters WA (1991) Autacoids and the control of vascular tone in the human umbilical-placental circulation. Placenta 12:453-477
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
7. Carter FB, Cherny WB, Crenshaw C (1962) Serotonin studies in abnormal pregnancies. Am J Obstet Gynecol 84:913-918
8. Cortijo J, Marti-Cabrera M, Bernabeu E, Doménech T, Bou J, Fernández AG, Beleta J, Palacios JM, Morcillo EJ (1997) Characterization of 5-HT receptors on human pulmonary artery and vein: Functional and binding studies. Br J Pharmacol 122:1455-1463
9. 2 receptors of 5-hydroxytryptamine-induced contractions of human placental vein. Gen Pharmacol 30:483-488
10. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102
11. 2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Br J Pharmacol 122:875-884
12. 1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein. Br J Pharmacol 126:437-442
13. Fox SB, Khong TY (1990) Lack of innervation of human umbilical cord. An immunohistological and histochemical study. Placenta 11:59-62
14. 1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery. Br J Pharmacol 127:1327-1336
15. 1D receptor subtypes. Trends Pharmacol Sci 17:103-105
16. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157-203
17. Israel SL, Seligson HT, Stroup PE, Seligson PE (1959) Serotonin in pregnant and parturient women. Obstet Gynecol 13:672
18. Jenkinson DH, Barnard EA, Hoyer D, Humphrey PP, Leff P, Shankley NP (1995) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev 47:255-266
19. Jones JB, Rowsell AJ (1973) Fetal 5-hydroxytryptamine levels in late pregnancy. Obstet Gynaecol Br Commonw 80:687-689
20. Karen Z, Pfeifer Y, Sulman FG (1965) Serotonin content of human placenta and fetus during pregnancy. Am J Obstet Gynecol 93:411-415
21. Kenakin TP (1992) Tissue response as a functional discriminator of receptor heterogeneity: Effects of mixed receptor populations on Schild regressions. Mol Pharmacol 41:699-707
22. Krupp P, Krupp I (1960) Serotonin and toxemia of pregnancy. Obstet Gynecol 15:237-240
23. 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br J Pharmacol 120:819-826
24. 2 receptors. Life Sci 28:1015-1022
25. 2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21:301-314
26. Lovren F, Li XF, Lytton J, Triggle C (1999) Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery. Br J Pharmacol 127:1247-1255
27. Maayani S, Wilkinson CW, Stollak JS (1984) 5-Hydroxytryptamine receptor in rabbit aorta: Characterization by butyrophenone analogs. J Pharmacol Exp Ther 229:346-350
28. 1-like receptor-mediated vasoconstriction in human pulmonary artery. Br J Pharmacol 119:277-282
29. MacLennan SJ, Whittle MJ, McGrath JC (1989) 5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery. Br J Pharmacol 97:921-933
30. Martin GR (1998) 5-Hydroxytryptamine receptors. In: IUPHAR (ed) The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media, Girdleston, pp 167-185
31. 1B receptor. Br J Pharmacol 128:730-734
32. Munson PS, Rodbard D (1984) Ligand: A reversible computerized approach to characterization of ligand binding system. Anal Biochem 107:220-239
33. Murray DL, Purdy RE (1985) Potentiation of serotonergic receptor blockade by alpha-adrenoceptor antagonists. Proc West Pharmacol Soc 28:93-95
34. Mylecharane EJ (1990) Mechanisms involved in serotonin-induced vasodilatation. Blood Vessels 27:116-126
35. Nilsson T, Longmore J, Shaw D, Pantev E, Bard JA, Branchek T, Edvinsson L (1999) Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 372:49-56
36. Purdy RE, Hurlbut DE, Rains LA (1981) Receptors for 5-hydroxytryptamine in rabbit isolated ear artery and aorta. Blood Vessels 18:16-27
37. Purdy RE, Murray DL, Stupecky GL (1987) Receptors for 5-hydroxytryptamine in rabbit blood vessels: Activation of alpha adrenoceptors in rabbit thoracic aorta. J Pharmacol Exp Ther 240:535-541
38. Reilly RD, Russell PT (1977) Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat Rec 188:277-286
39. Spivack M (1946) The anatomic peculiarities of the human umbilical cord and their clinical significance. Am J Obstet Gynecol 52:387-401
40. Tuncer M, Dogan N, Oktay S, Kayaalp SO (1985) Receptor mechanisms for 5-hydroxytryptamine in isolated human umbilical artery and vein. Arch Int Pharmacodyn 276:17-27
41. Ullmer C, Schmuck K, Kalkman HO, Lubbert H (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370:215-221
42. 3H]spiperone. J Recept Res 14:11-22
43. Vanhoutte PM (1983) Introductory remarks: Why 5-hydroxytryptamine? Fed Proc 42:211-212
44. Van Nueten JM, Janssen PA, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217-230
45. Verheggen R, Hundeshagen AG, Brown AM, Schindler M, Kaumann AJ (1998) 5-HT1B receptor-mediated contractions in human temporal artery: Evidence from selective antagonists and 5-HT receptor mRNA expression. Br J Pharmacol 124:1345-1354
46. Weiner CP, Gelfan R, Socol ML (1984a) Intrapartum treatment of preeclamptic hypertension by ketanserin, a serotonin receptor antagonist. Am J Obstet Gynecol 149:576-578
47. Weiner CP, Socol ML, Vaisrub N (1984b) Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist. Am J Obstet Gynecol 149:496-500
48. Westphal RS, Sanders-Bush E (1994) Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol Pharmacol 46:937-942
49. Whigham KA, Hotwie PW, Drummond AH, Prentice CR (1978) Abnormal platelet function in pre-eclampsia. Br J Obstet Gynaecol 85:28-32